ARCHIVES

Bush Limits Drug Company Efforts To Block Generics

This article is from The Cancer Letter archive.

Vol. 28 No. 39 | October 25, 2002

Download PDF Visit The Full Archive

Related Articles

FDA Committee nixes Combination Guidelines, Okays New NDA Policy

January 21, 1977

FDA Discloses Responses, Toxicities For Burzynski’s “Antineoplastons”

April 24, 1998

Rauscher, ACS Oppose Kennedy Bill, Defend NCI Special Authority, Say Funding Level Inadequate

May 11, 1979

In Brief: Mauer to Leave St. Jude For U. Tennessee As Cancer Program Director; Harvard, MIT Share ACS Award

July 29, 1983

Reaction To PSA Guideline Muffled Compared to 2009 Mammography Guideline

October 14, 2011

Move to Boycott Cancer Congress Gains Some Support

January 20, 1978